Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture. (Q48951262)

17 February 2018

title

Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture. (English)

1 reference

17 February 2018

author name string

Fanchin R

1

1 reference

17 February 2018

Hourvitz A

2

1 reference

17 February 2018

Olivennes F

3

1 reference

17 February 2018

Taieb J

4

1 reference

17 February 2018

Hazout A

5

1 reference

17 February 2018

Frydman R

6

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

17 February 2018

published in

Fertility and Sterility

1 reference

17 February 2018

volume

68

1 reference

17 February 2018

issue

4

1 reference

17 February 2018

page(s)

648-652

1 reference

17 February 2018

Premature progesterone elevation does not alter oocyte quality in in vitro fertilization.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Premature plasma progesterone and androgen elevation are not prevented by adrenal suppression in in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Physiopathology of premature progesterone elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Endocrinology: Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. I. Sex steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Pregnancy rates in donors versus recipients according to the serum progesterone level at the time of human chorionic gonadotropin in a shared oocyte program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Four indications for embryo transfer at the blastocyst stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

The effect of progesterone administration in the follicular phase of an artificial cycle on endometrial morphology: a model of premature luteinization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Hormonal control of endometrial receptivity. The egg donation model and controlled ovarian hyperstimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

Potential enhancement of endometrial receptivity in cycles using controlled ovarian hyperstimulation with antiprogestins: a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2980464-5

10.1016/S0015-0282(97)80464-5

7 January 2021

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018